10:11 AM EST, 01/14/2025 (MT Newswires) -- Medtronic ( MDT ) said late Monday that the US Centers for Medicare & Medicaid Services, or CMS, is introducing a national coverage analysis on renal denervation.

The CMS will evaluate and develop a national Medicare coverage policy for renal denervation methods for patients with hypertension, the company added.

The agency initiated this analysis in response to the company's request for supporting Medicare beneficiary access to the symplicity spyral renal denervation system, Medtronic ( MDT ) said.

The CMS expects to complete the national coverage analysis on Oct. 11, according to Medtronic ( MDT ).

Shares of Medtronic ( MDT ) were up 3% in recent Tuesday trading.

Price: 84.29, Change: +2.50, Percent Change: +3.06